1.71 USD
-1.44 (-45.71%)
2.16 USD
+0.45 (+26.32%)
Taking everything into account, APTO scores 1 out of 10 in our fundamental rating. APTO was compared to 525 industry peers in the Biotechnology industry. APTO has a bad profitability rating. Also its financial health evaluation is rather negative. APTO does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year APTO has reported negative net income.
- In the past year APTO has reported a negative cash flow from operations.
- In the past 5 years APTO always reported negative net income.
- APTO had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -327.57%, APTO is not doing good in the industry: 95.09% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -327.57% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-185.13%
ROA(5y)-125.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- APTO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- APTO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -79.84, we must say that APTO is in the distress zone and has some risk of bankruptcy.
- With a Altman-Z score value of -79.84, APTO is not doing good in the industry: 95.96% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -79.84 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 1.05 indicates that APTO should not have too much problems paying its short term obligations.
- The Current ratio of APTO (1.05) is worse than 87.89% of its industry peers.
- A Quick Ratio of 1.05 indicates that APTO should not have too much problems paying its short term obligations.
- APTO has a worse Quick ratio (1.05) than 86.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
- APTO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -237.66%.
EPS 1Y (TTM)-237.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- APTO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.16% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.43%
EPS Next 2Y38.98%
EPS Next 3Y26.36%
EPS Next 5Y17.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for APTO. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APTO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as APTO's earnings are expected to grow with 26.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.98%
EPS Next 3Y26.36%
5. Dividend
5.1 Amount
- APTO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
APTOSE BIOSCIENCES INC / APTO FAQ
What is the ChartMill fundamental rating of APTOSE BIOSCIENCES INC (APTO) stock?
ChartMill assigns a fundamental rating of 1 / 10 to APTO.
Can you provide the valuation status for APTOSE BIOSCIENCES INC?
ChartMill assigns a valuation rating of 1 / 10 to APTOSE BIOSCIENCES INC (APTO). This can be considered as Overvalued.
Can you provide the profitability details for APTOSE BIOSCIENCES INC?
APTOSE BIOSCIENCES INC (APTO) has a profitability rating of 0 / 10.
What is the financial health of APTOSE BIOSCIENCES INC (APTO) stock?
The financial health rating of APTOSE BIOSCIENCES INC (APTO) is 1 / 10.
What is the earnings growth outlook for APTOSE BIOSCIENCES INC?
The Earnings per Share (EPS) of APTOSE BIOSCIENCES INC (APTO) is expected to grow by 91.43% in the next year.